Subscribe
Menu
Login
Search
Login
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
May 2022, Issue 2
Preview This Issue
Archives
Features
Quarterly Magazine
Current Issue
Spring 2022
Preview This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
Multimedia
Crossword Puzzles
Infographics
Science Snapshot
Videos
Webinars
Research Resources
Podcasts
Events
Infographics
eBooks
Videos
The Scientist University
Research Products Blog
Articles
Subscribe
Home
Subjects
personal omics
personal omics
23andMe Markets Genome Kits to Researchers
Kerry Grens | Jul 14, 2016
Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.
Following FDA OK, 23andMe to Expand Health Prediction
Kerry Grens | Oct 21, 2015
The personal genomics firm is ramping up its suite of disease-related genetic tests.
Venter Enters the Consumer Genomics Biz
Bob Grant | Sep 22, 2015
The genomic entrepreneur has struck a deal with a South African health insurer to sequence the exomes of its customers.
Direct-to-Consumer Liquid Biopsy
Kerry Grens | Sep 13, 2015
Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.
Illumina, Investors Launch Consumer Genetics Firm
Tracy Vence | Aug 19, 2015
With $100 million in initial funding, Helix aims to make personal genomics accessible.
23andMe Enters Drug Development
Kerry Grens | Mar 12, 2015
The personal genomics firm announces plans to make medicines.
FDA OKs 23andMe Test
Kerry Grens | Feb 20, 2015
The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.
23andMe Partners with Pfizer
Jef Akst | Jan 13, 2015
The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.
23andMe Expands to U.K.
Kerry Grens | Dec 2, 2014
British consumers can buy the genetic testing-associated health prediction service forbidden by the US government.
On Race and Medicine
Keith Norris | Feb 1, 2014
Until health care becomes truly personalized, race and ethnicity will continue to be important clues guiding medical treatments.
$1,000 Genome at Last?
Tracy Vence | Jan 15, 2014
Illumina says its newest sequencing system can churn out whole human genomes for $1,000 apiece.
GeneLink Settles
Abby Olena | Jan 14, 2014
Another personal genomics company faces government pressure—this time from the Federal Trade Commission.
Speaking of Science
The Scientist
Staff | Jan 1, 2014
January 2014's selection of notable quotes
23andMe Steps Back
Abby Olena | Dec 6, 2013
The company announces that it will stop offering health interpretations of personal genetic data.
23andMe Now Facing Lawsuit
Kerry Grens | Dec 4, 2013
Shortly after getting in trouble with the Food and Drug Administration, the personal genetic testing company is slapped with a class action lawsuit.
FDA to 23andMe: Stop Marketing Kits
Kerry Grens | Nov 26, 2013
The US Food and Drug Administration blocks the marketing of unapproved genetic tests.
Genetics Firm Gets Baby-Predicting Patent
Bob Grant | Oct 4, 2013
23andMe denies that its new patent will be used to help couples create designer babies based on personal genetic testing.
N=Me
Kerry Grens | Aug 1, 2013
Science gets personal as researchers—professional and amateur—plumb the depths of their own molecular biology.
Track Thyself
Kerry Grens | Jul 31, 2013
Meet Larry Smarr, a UC San Diego computer scientist who records several facets of his physiology, on the hunt for signs of present or future health problems.